Success Metrics

Clinical Success Rate
87.5%

Based on 21 completed trials

Completion Rate
88%(21/24)
Active Trials
2(7%)
Results Posted
62%(13 trials)
Terminated
3(10%)

Phase Distribution

Ph not_applicable
8
27%
Ph phase_2
5
17%
Ph phase_1
1
3%
Ph phase_3
4
13%
Ph early_phase_1
1
3%
Ph phase_4
9
30%

Phase Distribution

2

Early Stage

5

Mid Stage

13

Late Stage

Phase Distribution28 total trials
Early Phase 1First-in-human
1(3.6%)
Phase 1Safety & dosage
1(3.6%)
Phase 2Efficacy & side effects
5(17.9%)
Phase 3Large-scale testing
4(14.3%)
Phase 4Post-market surveillance
9(32.1%)
N/ANon-phased studies
8(28.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

84.0%

21 of 25 finished

Non-Completion Rate

16.0%

4 ended early

Currently Active

2

trials recruiting

Total Trials

30

all time

Status Distribution
Active(3)
Completed(21)
Terminated(4)
Other(2)

Detailed Status

Completed21
Terminated3
unknown2
Active, not recruiting1
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
30
Active
2
Success Rate
87.5%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (3.6%)
Phase 11 (3.6%)
Phase 25 (17.9%)
Phase 34 (14.3%)
Phase 49 (32.1%)
N/A8 (28.6%)

Trials by Status

active_not_recruiting13%
not_yet_recruiting13%
recruiting13%
completed2170%
terminated310%
unknown27%
withdrawn13%

Recent Activity

Clinical Trials (30)

Showing 20 of 30 trialsScroll for more
NCT07524725Not Applicable

Effect of Behavioral Intervention (Baduanjin Alone or Laughter Exercise Plus Artificial Tears) Versus Artificial Tear on Dry Eye Disease: a Randomised Controlled Trial

Not Yet Recruiting
NCT06544694Phase 3

A Study to Investigate the Effect of 0.003% AR-15512 on Subjects With Dry Eye Disease

Completed
NCT04149210Phase 3

FLuorometholone as Adjunctive MEdical Therapy for TT Surgery (FLAME) Trial

Completed
NCT06660290Phase 3

A Study to Evaluate 0.003% AR-15512 Safety and Drop Attributes

Completed
NCT05692739Phase 4

Clinical Trial To Determine The Effectiveness And Safety Of Topical Insulin In Dry Eye

Completed
NCT07185854Not Applicable

Medical vs Acupuncture for Dry Eye

Completed
NCT05896670Phase 2

Safety and Efficacy of Licaminlimab Ophthalmic Solution for the Treatment of Dry Eye Disease

Completed
NCT06865144Phase 4

Effect of Rhopressa on Intraocular Pressure (IOP) in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension Post-SLT

Recruiting
NCT06752278Not Applicable

Efficacy of Pilocarpine As a Secretagogue Versus Artificial Tears for the Treatment of Dry Eye

Completed
NCT04118920Phase 1

Safety of Topical Insulin Drops for Open-angle Glaucoma

Active Not Recruiting
NCT04327999Phase 2

Effect of Artificial Tears on Radioiodine Levels in the Nasolacrimal Duct System

Terminated
NCT01144494Early Phase 1

Aqueous Humor Dynamics and Brimonidine

Completed
NCT00836485Phase 2

Evaluation of the Safety and Efficacy of Ketotifen 4.0% Patch as Compared to Placebo Patch, Olopatadine 0.2% Ophthalmic Solution, and Artificial Tears in the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis

Completed
NCT04343222Phase 4

Control of Pain in Intravitreal Injections Using Topical NSAIDs

Completed
NCT05307081

An Observational, Qualitative Study Assessing Eye Drop Administration

Unknown
NCT04193774Not Applicable

Optimization of Sampling and Processing of Samples for Molecular Microbial Research on Ocular Surface Samples

Completed
NCT02472223Not Applicable

Reducing Adenoviral Patient Infected Days

Completed
NCT02845336Phase 2

Celecoxib for Thyroid Eye Disease

Terminated
NCT03034772Phase 2

Dorzolamide-timolol in Combination With Anti-vascular Endothelial Growth Factor Injections for Wet Age-related Macular Degeneration

Completed
NCT01614847Phase 4

Tear Osmolarity Changes After Instilling Isotonic Hyaluronate Artificial Tears

Completed

Drug Details

Intervention Type
DRUG
Total Trials
30